Dockendorff Charles J
SEC CIK 1400563 · EDGAR
BoughtSold
Most active insiders at KEYS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Nersesian Ronald S. | Dir | — | $14.49M |
| 2 | Dhanasekaran Satish | Pres, CEO, Dir | — | $4.52M |
| 3 | PAGE JOHN | SVP | — | $3.83M |
| 4 | Estrada Ingrid A | SVP | — | $3.39M |
| 5 | Dougherty Neil | EVP, CFO | — | $1.48M |
| 6 | Li Jeffrey K | SVP, Sec | — | $1.38M |
| 7 | CULLEN JAMES | Dir | — | $1.04M |
| 8 | NYE JEAN MCCLUNG | Dir | — | $957.7K |
| 9 | NARAYANAN KAILASH | SVP | — | $628.7K |
| 10 | JUSKIE JO ANN | SVP | — | $304.4K |
| 21 | Dockendorff Charles J | Dir | — | — |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-24 | 2026-03-20 | KEYS | Keysight Technologies | Dockendorff Charles J | Dir | A - Grant | $0.00 | +870 | 55.2K | +2% | $0 | |
| 2025-07-25 | 2025-07-24 | HAE | HAEMONETICS CORP | Dockendorff Charles J | Dir | A - Grant | — | +2,693 | 7,126 | +61% | — | |
| 2025-03-25 | 2025-03-21 | KEYS | Keysight Technologies | Dockendorff Charles J | Dir | A - Grant | $0.00 | +1,589 | 54.3K | +3% | $0 | |
| 2024-07-26 | 2024-07-25 | HAE | HAEMONETICS CORP | Dockendorff Charles J | Dir | A - Grant | — | +2,207 | 4,433 | +99% | — | |
| 2024-05-13 | 2024-05-09 | BSX | Boston Scientific | Dockendorff Charles J | Dir | A - Grant | $0.00 | +2,901 | 2,901 | New | $0 | |
| 2024-05-08 | 2024-05-07 | BSX | Boston Scientific | Dockendorff Charles J | Dir | S - Sale | $72.70 | -3,946 | 0 | -100% | -$286.9K | |
| 2024-03-26 | 2024-03-22 | KEYS | Keysight Technologies | Dockendorff Charles J | Dir | A - Grant | $0.00 | +1,632 | 52.8K | +3% | $0 | |
| 2023-09-07 | 2023-09-05 | HAE | HAEMONETICS CORP | Dockendorff Charles J | Dir | S - Sale | $87.68 | -10.2K | 2,226 | -82% | -$895.7K | |
| 2023-08-18 | 2023-08-18 | BSX | Boston Scientific | Dockendorff Charles J | Dir | S - Sale | $50.74 | -17.1K | 3,946 | -81% | -$866.6K | |
| 2023-08-08 | 2023-08-04 | HAE | HAEMONETICS CORP | Dockendorff Charles J | Dir | A - Grant | — | +2,226 | 12.4K | +22% | — | |
| 2023-05-05 | 2023-05-04 | BSX | Boston Scientific | Dockendorff Charles J | Dir | A - Grant | $0.00 | +3,946 | 21.0K | +23% | $0 | |
| I | 2023-05-05 | 2023-01-06 | BSX | Boston Scientific | Dockendorff Charles J | Dir | G - Gift | $0.00 | -8,201 | 0 | -100% | $0 |
| 2023-03-21 | 2023-03-17 | KEYS | Keysight Technologies | Dockendorff Charles J | Dir | A - Grant | $0.00 | +1,543 | 51.1K | +3% | $0 | |
| I | 2023-01-10 | 2023-01-06 | KEYS | Keysight Technologies | Dockendorff Charles J | Dir | G - Gift | $0.00 | -2,844 | 0 | -100% | $0 |
| 2022-12-14 | 2022-12-12 | KEYS | Keysight Technologies | Dockendorff Charles J | Dir | G - Gift | $0.00 | -7,551 | 55.7K | -12% | $0 | |
| 2022-12-14 | 2022-12-13 | KEYS | Keysight Technologies | Dockendorff Charles J | Dir | S - Sale | $185.06 | -3,257 | 52.4K | -6% | -$602.7K | |
| 2022-08-08 | 2022-08-05 | HAE | HAEMONETICS CORP | Dockendorff Charles J | Dir | A - Grant | — | +2,730 | 28.1K | +11% | — | |
| 2022-05-09 | 2022-05-05 | BSX | Boston Scientific | Dockendorff Charles J | Dir | A - Grant | $0.00 | +4,877 | 17.1K | +40% | $0 | |
| 2022-03-22 | 2022-03-18 | KEYS | Keysight Technologies | Dockendorff Charles J | Dir | A - Grant | $0.00 | +1,626 | 63.2K | +3% | $0 | |
| 2021-08-09 | 2021-08-06 | HAE | HAEMONETICS CORP | Dockendorff Charles J | Dir | A - Grant | — | +3,077 | 25.4K | +14% | — |
Purchase Sale Sale after option exercise All abbreviations